NewsRoom Articles - Page 106 of 238

TuesdayFeb 14, 2023 1:26 pm

Research Finds Most Pediatric Oncologists Don’t Discuss Prognosis with Caregivers

The American Cancer Society estimates that around 9,910 children under the age of 15 will be diagnosed with cancer this year. Pediatric cancer is the second largest cause of death in children up to 14 years of age in the United States, and the disease is expected to take the lives of 1,040 children under 15 years in 2023. According to the World Health Organization, around 400,000 children aged 0 to 19 years of age are estimated to develop cancer worldwide annually. Advancements in medicine have allowed physicians to detect pediatric cancer earlier and avoid treatment delays, resulting in around…

MondayFeb 13, 2023 12:59 pm

Research Discovers Apathy in Mild Cognitive Impairment Patients May Increase Risk of Alzheimer’s

A recent study carried out by UTHealth Houston investigators has revealed that the presence of apathy in patients suffering from mild cognitive impairments may be a precursor to Alzheimer’s disease. Alzheimer's is a debilitating mental disorder that usually causes memory loss, poor judgment, personality changes and a general decline in cognitive faculties. While it is estimated to affect more than 6 million Americans of all ages, a majority of the people with Alzheimer’s are over the age of 75. Memory problems are usually the first clear sign of Alzheimer’s in a patient, but for the most part, physicians cannot detect…

MondayFeb 13, 2023 9:45 am

BiondVax Pharmaceuticals Ltd.’s (NASDAQ: BVXV) COVID-19 NanoAb Takes Centerstage at the 2023 BIO CEO & Investor Conference

Amir Reichman, BiondVax CEO, represented the company at this year’s BIO CEO & Investor Conference held at the Marriott Marquis, New York, on February 6-8 His presentation focused on the company’s recent successful pre-clinical in vivo results on its innovative inhaled COVID-19 treatment Additional results from the study were release in January 2023, indicating that, compared to the control group, hamsters that received the drug one day after infection had negligible SARS-CoV-2 vital titers in their lungs and experienced a significantly milder and shorter illness BiondVax’s management is optimistic that its self-administered inhaled NanoAbs will be highly attractive to at-risk…

FridayFeb 10, 2023 11:05 am

Study Discovers Antidepressants Are Ineffective Against Chronic Pain

A recent study published in “The British Medical Journal” has revealed that antidepressants may be ineffective at alleviating the discomfort caused by chronic pain. Antidepressants, as their name suggests, have repeatedly proven to be effective at treating the symptoms of a myriad of mental health disorders. They are especially effective at providing quick relief for people suffering from severe depression, a condition that is thought to affect millions of people in America and around the world. The use of antidepressants among patients has been on the rise over the past couple of decades and surged during the coronavirus pandemic, when…

ThursdayFeb 09, 2023 12:44 pm

Study Links Sugary Beverage Intake to Hair Loss in Men

Male pattern hair loss is the most common type of hair loss in men. The U.S. National Library of Medicine estimates that more than 50% of men above the age of 50 will experience some level of male pattern hair loss (MPHL). While male pattern baldness can begin during the teenage years for some people, it is much more common in adult men, with its chance of developing increasing as individuals grow older. Research has indicated that rates of male pattern hair loss may be on the rise, with a Chinese survey indicating that the condition affected more than 27%…

ThursdayFeb 09, 2023 10:30 am

Nemaura Medical, Inc. (NASDAQ: NMRD) Featured in Coverage of The MicroCap Rodeo’s 3rd Annual Winter Wonderful and Best Ideas Investor Conference

Nemaura Medical (NASDAQ: NMRD) is a medical technology company developing and commercializing non-invasive wearable diagnostic devices. The company is currently commercializing sugarBEAT(R) and proBEAT(TM). sugarBEAT(R), a CE mark approved Class IIb medical device, is a non-invasive and flexible continuous glucose monitor (“CGM”) providing actionable insights derived from real time glucose measurements and daily glucose trend data, which may help people with diabetes and pre-diabetes to better manage, reverse, and prevent the onset of diabetes. Nemaura has submitted a PMA (Premarket Approval Application) for sugarBEAT(R) to the U.S. FDA. proBEAT(TM) combines non-invasive glucose data processed using artificial intelligence and a digital healthcare…

WednesdayFeb 08, 2023 12:13 pm

Food Allergies Worsen Cost of Living for Impacted Individuals

An estimated 32 million Americans, including 26 million adults and 5.6 million minors, live with a food allergy. For many of these Americans, their day-to-day lives involve avoiding certain foods that can trigger moderate to severe allergic reactions. However, subsisting on such a restricted diet can be pretty costly, especially if affected persons are allergic to a range of foods. As the cost of living increases amid global supply chain issues and inflation, people with food allergies are experiencing even higher living costs than those without allergies. Data collected by the Allergy Team has revealed that families living on restricted…

WednesdayFeb 08, 2023 9:45 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Encouraged by Nanosized Antibody Study Results as Market Forecasts Predict Rapid Growth

Market analysts predict monoclonal antibodies (“mAbs”) will be the fastest-growing revenue segment of the biologics medicinal market through the end of the decade BiondVax Pharmaceuticals is focused on developing and commercializing novel mAb “biobetter” NanoAbs to meet underserved medical needs addressing large market disorders The company’s recent work with an inhaled nanosized antibody for COVID has shown exceptionally promising results, virtually preventing illness and eliminating the SARS-COV-2 virus in a hamster population With COVID as first target, the company’s pipeline aims to provide effective medical responses to other disorders such asthma, psoriasis, psoriatic arthritis, and macular degeneration Immunotherapeutic product innovator…

TuesdayFeb 07, 2023 12:24 pm

New Model Sheds Light on Patterns of Infectious Illnesses

The COVID-19 pandemic was a major reminder of just how problematic infectious diseases can be, especially if we aren’t intimately aware of their spread patterns. Only a few months after the disease was discovered in Wuhan, China, significant chunks of the world were shut down to avoid mass infections that would place undue strain on their medical systems. Even though we are now out of the eye of the storm, it is important that we understand how such infectious diseases behave to prevent future pandemics. Fortunately, a new modeling approach capable of accounting for contact patterns between different age groups…

MondayFeb 06, 2023 11:15 am

MetAlert, Inc. (MLRT) – Developing New and Practical GPS Tracking and Other Health Tech Solutions for Real-World Caregivers and Businesses

MetAlert, a developer of personal protective medical equipment and supplies, owes much of its growth to acting on feedback from real-world caregivers who use its products for the monitoring and tracking of vulnerable patients This connection with caregivers has yielded advanced products such as the award-winning, multi-patented GPS SmartSole, Invisabelt, Take-Along Tracker, and Rover Tracker, among others Attention to consumers has also led to its line of hearing aids, such as its flagship Hear IQ 4 rechargeable, app-controlled hearing aid, and its RoomMate wall-mounted 3D sensors for looking after patients without intruding on their personal space MetAlert (OTC: MLRT), a…

News and publishing service for medical and biotechnology related companies

Contact us: 512.354.7000

Research Finds Most Pediatric Oncologists Don’t Discuss Prognosis with Caregivers

Research Discovers Apathy in Mild Cognitive Impairment Patients May Increase Risk of Alzheimer’s

BiondVax Pharmaceuticals Ltd.’s (NASDAQ: BVXV) COVID-19 NanoAb Takes Centerstage at the 2023 BIO CEO & Investor Conference

Study Discovers Antidepressants Are Ineffective Against Chronic Pain

Study Links Sugary Beverage Intake to Hair Loss in Men

Nemaura Medical, Inc. (NASDAQ: NMRD) Featured in Coverage of The MicroCap Rodeo’s 3rd Annual Winter Wonderful and Best Ideas Investor Conference

Food Allergies Worsen Cost of Living for Impacted Individuals

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Encouraged by Nanosized Antibody Study Results as Market Forecasts Predict Rapid Growth

New Model Sheds Light on Patterns of Infectious Illnesses

MetAlert, Inc. (MLRT) – Developing New and Practical GPS Tracking and Other Health Tech Solutions for Real-World Caregivers and Businesses

Official NewsWire Relationships

BioMedWire Currently Accepts

BioMedWire

Company Search

Site Search